Fund For Medical Research And Education is categorized under Medical Research in Detroit, MI and active since 1979.
Fund For Medical Research And Education was established in 1979, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact John Crissman at the company’s single location by writing to 550 East Canfield St, Detroit, Michigan MI 48201 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Fund For Medical Research And Education |
| Contact Person: | John Crissman |
| Address: | 550 East Canfield St, Detroit, Michigan 48201 |
| Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
| Founded: | 1979 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Fund For Medical Research And Education was started in 1979 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact John Crissman for inquiries that concern Fund For Medical Research And Education by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Fund For Medical Research And Education can be found at the coordinates 42.355283,-83.054745 as well as the street address 550 East Canfield St in Detroit, Michigan 48201.
For its online presence, you may visit Fund For Medical Research And Education’s website at and engage with its social media outlets through on Twitter and on Facebook.